Correction: LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis | Synapse
March 3, 2026Open Access
Correction: LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis
Puntos clave
LINC01016 enhances the malignant phenotype of endometrial cancer cells, impacting their growth and survival with key molecular pathways involved.
The study identifies the relation between LINC01016 and two microRNAs: miR-302a-3p and miR-3130-3p, with potential implications for targeted therapy.
Assessment using molecular pathway analysis demonstrates how LINC01016 regulates NFYA and SATB1 within cancer cells, supporting the hypothesis of a regulatory axis.
These findings suggest that targeting LINC01016 may enable new therapeutic approaches for endometrial cancer; additional research is warranted.